Login
$AZN
$184.02 After hours

Company Executives

Officer In this role Source
Pam Cheng
Executive Vice-President, Global Operations, IT & Chief Sustainability Officer
Not stated
Marc Dunoyer
CEO, Alexion and Chief Strategy Officer, AstraZeneca
Not stated
Jeff Pott
Chief Human Resources Officer, Chief Compliance Officer and General Counsel
Not stated
Sharon Barr
Executive Vice-President, Biopharmaceuticals R&D
Since 2023
3 years
Ruud Dobber
Executive Vice-President, BioPharmaceuticals Business Unit
Since 2019
7 years
David Fredrickson
Executive Vice-President, Oncology Haematology Business Unit
Since 2017
9 years
Susan Galbraith
Executive Vice-President, Oncology Haematology R&D
Since 2021
5 years
Iskra Reic
Executive Vice-President, International
Since 2024
2 years
Mani Sharma
See remarks
Title from the Form 4 dated Nov 6, 2026
Not stated

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

We could not read this board reliably

Rather than show a list that might be wrong, we show nothing. The board is in the 20-F filed Feb 24, 2026.

Read the board in the 20-F

No proxy statement on record

Related-party transactions come from the company’s proxy statement. ASTRAZENECA PLC has not filed one with the SEC.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support